Clariant AG (SWX:CLN)
Switzerland
· Delayed Price · Currency is CHF | Market Cap | 2.62B |
| Revenue (ttm) | 3.92B |
| Net Income (ttm) | -75.00M |
| Shares Out | 328.88M |
| EPS (ttm) | -0.23 |
| PE Ratio | n/a |
| Forward PE | 10.67 |
| Dividend | 0.42 (5.27%) |
| Ex-Dividend Date | Jun 2, 2025 |
| Volume | 500,221 |
| Average Volume | 809,160 |
| Open | 7.99 |
| Previous Close | 7.97 |
| Day's Range | 7.94 - 8.07 |
| 52-Week Range | 6.55 - 9.83 |
| Beta | 0.45 |
| RSI | 50.24 |
| Earnings Date | May 8, 2026 |
About Clariant AG
Clariant AG develops, manufactures, distributes, and sells specialty chemicals in Switzerland, Europe, the Middle East, Africa, the United States, and the Asia Pacific. It operates through Care Chemicals, Catalysts, and Adsorbents & Additives segments. The Care Chemicals segment offers personal and home care, crop solutions, industrial applications, base chemicals, oil services, and mining solutions for various applications in home and personal care, coatings, adhesives, and agriculture, and food. The Catalysis segment provides business service... [Read more]
Financial Performance
Financial StatementsNews
Clariant's 31st Annual General Meeting approves all agenda items
Management Report, Financial Statements and Consolidated Financial Statements, Non-financial Report, and Compensation Report of Clariant for the 2025 financial year approvedStable distribution of C...
Clariant publishes Integrated Report 2025
Clariant has released its Integrated Report 2025, which provides a comprehensive overview of both the company's financial and non-financial performance
Clariant AG Earnings Call Transcript: Q4 2025
Delivered flat sales and improved EBITDA margin in 2025 amid challenging markets, with strong cash conversion and progress on cost savings. Outlook for 2026 is cautious, with flat sales and further margin improvement targeted, supported by ongoing restructuring and disciplined capital allocation.
Clariant delivers third year of strong EBITDA margin improvement – EBITDA margin before exceptional items up 180 basis points versus prior year to 17.8 %
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR FOURTH QUARTER / FULL YEAR | 2025 Q4 2025 sales increased by 1 % in local currencies 1 to CHF 1.028 billion due to strong volume growth in Catalysts and Car...
Clariant acknowledges the agreement between Wendel SE and Henkel on the acquisition of Stahl
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Muttenz, 04 February 2026 Clariant, a sustainability-focused specialty chemical company, acknowledges the agreement between Stahl Group's majority and cont...
Clariant Board of Directors proposes the election of Regula Wallimann and Albert Manifold to the Board
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Muttenz, 19 January 2026 Clariant, a sustainability-focused specialty chemical company, today announced that the Board of Directors decided to propose to ...
Clariant rejects allegations from MOL Group and Braskem against four companies related to the 2020 competition law infringement
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Clariant, a sustainability-focused specialty chemical company, today announced that the company received two claims for damages against four companies, inclu...
Clariant announces the divestment of its business in Venezuela
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Clariant announces the divestment of its business in Venezuela MUTTENZ, DECEMBER 19, 2025 Clariant, a sustainability-focused specialty chemical company, to...
Clariant announces leadership transition in its Business Unit Care Chemicals
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Marcelo Lu to join Clariant in January 2026 as President Designate for Care Chemicals & Americas and Member of Executive Steering Committee Planned successio...
Clariant CEO: China chemicals market bigger than U.S. and Europe combined
Clariant CEO: China chemicals market bigger than U.S. and Europe combined.
Clariant AG Earnings Call Transcript: Q3 2025
Q3 2025 saw EBITDA growth and margin improvement despite lower sales, driven by cost savings and performance programs. Guidance for 2025 remains at the low end of sales growth and 17%-18% EBITDA margin, with continued focus on cash conversion and structural cost actions.
Clariant increases Q3 2025 EBITDA margin before exceptional items by 230 basis points to 17.9 % in continued challenging market environment
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR THIRD QUARTER/NINE MONTHS | 2025 Q3 2025 sales decreased by 3 % in local currencies 1 to CHF 906 million, as modest growth in Adsorbents & Additives was off...
Clariant Board of Directors decided to reduce its size and enhance corporate governance
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Clariant Board of Directors decided to reduce its size and enhance corporate governance Muttenz, 24 October 2025 Clariant, a sustainability-focused speci...
Clariant rejects allegations from BP Europe and ExxonMobil against four companies related to the 2020 competition law infringement
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Muttenz, 03 October 2025 Clariant, a sustainability-focused specialty chemical company, today announced that on 02 October 2025, the company received two c...
Clariant AG Earnings Call Transcript: Q2 2025
Q2 2025 saw strong profitability with EBITDA margin before exceptionals up to 17.5% and robust cost savings, despite flat sales in local currency and ongoing market headwinds. Guidance for 2025 was revised to 1–3% sales growth, with profitability targets maintained.
Clariant delivers strong profitability on flat local currency sales in Q2 2025
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR SECOND QUARTER/FIRST HALF YEAR | 2025 Q2 2025 sales of CHF 968 million were flat in local currencies 1 , as growth in Catalysts and Adsorbents & Additives of...
Clariant vows to fight ethylene purchasing claim filed by OMV
Switzerland's Clariant said on Tuesday it has received a 1-billion-euro ($1-billion) damages claim by Austrian energy company OMV alleging infringement of competition law on the ethylene purchasing ma...
Clariant rejects OMV's allegations against four companies related to the 2020 competition law infringement
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Muttenz, 27 May 2025 Clariant, a sustainability-focused specialty chemical company, today announced that on 26 May 2025, the company received a claim for dam...
Clariant rejects Dow Europe's allegations against four companies related to the 2020 competition law infringement
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Muttenz, 12 May 2025 Clariant, a sustainability-focused specialty chemical company, today announced that on 9 May 2025, the company received a claim for dama...
Clariant AG Earnings Call Transcript: Q1 2025
Q1 2025 saw 1% local currency sales growth and a 3% EBITDA increase, with margin improvement driven by cost savings and strong Lucas Meyer Cosmetics performance. Guidance remains cautious amid trade tensions, with most restructuring charges front-loaded in H1.
Clariant delivers further improved profitability in challenging environment – outlook confirmed
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR FIRST QUARTER | 2025 Q1 2025 sales increased by 1 % in local currencies 1 to CHF 1.013 billion, driven by organic growth in Care Chemicals and Adsorbents & A...
Clariant's 30th Annual General Meeting approves all agenda items
Shareholders approve the Integrated Report 2024, Financial Statements, and Consolidated Financial Statements Ben van Beurden elected as new Chairman of the Board of Directors Distribution of CHF 0.42 ...
Clariant presents Integrated Report 2024
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Clariant has released its Integrated Report 2024, which provides a comprehensive overview of both the company's financial performance and non-financial activ...
Direct impact of trade tariffs are fairly modest, says Clariant CEO
Conrad Keijzer, CEO of Clariant, says the direct impact of trade tariffs on the Swiss chemicals business is fairly modest due to the global nature of the firm's operations.
Clariant AG Earnings Call Transcript: Q4 2024
2024 results met guidance with CHF 4.152 billion sales and 15.8% EBITDA margin, despite a challenging macro environment. 2025 outlook targets 3%-5% sales growth, 17%-18% EBITDA margin before exceptionals, and continued cost savings, with strong performance in Care Chemicals and Adsorbents & Additives.